EFFECTIVENESS AND TOLERABILITY OF LONG-TERM TREATMENT WITH CABERGOLINE, A NEW LONG-LASTING ERGOLINE DERIVATIVE, IN HYPERPROLACTINEMIC PATIENTS

被引：64

作者：

CICCARELLI, E

GIUSTI, M

MIOLA, C

POTENZONI, F

SGHEDONI, D

CAMANNI, F

GIORDANO, G

机构：

[1] UNIV TURIN, DEPT BIOMED, DIV ENDOCRINOL, I-10124 TURIN, ITALY

[2] UNIV TURIN, INST RADIOL, I-10124 TURIN, ITALY

[3] FARMITALIA CARLO ERBA SPA, RES & DEV, MILAN, ITALY

[4] UNIV GENOA, IST SCI MED INTERNA, DIV ENDOCRINOL, I-16132 GENOA, ITALY

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1989年 / 69卷 / 04期

关键词：

D O I：

10.1210/jcem-69-4-725

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：725 / 728

页数：4

共 13 条

[1] LONG-TERM TREATMENT WITH ORAL SINGLE ADMINISTRATION OF BROMOCRIPTINE IN PATIENTS WITH HYPERPROLACTINEMIA [J].

CICCARELLI, E ;

MAZZA, E ;

GHIGO, E ;

GUIDONI, F ;

BARBERIS, A ;

MASSARA, F ;

CAMANNI, F .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (01) :51-53

[2] EFFECTS OF A NEW LONG-ACTING FORM OF BROMOCRIPTINE ON TUMOROUS HYPERPROLACTINEMIA [J].

CICCARELLI, E ;

GHIGO, E ;

MAZZA, E ;

ANDREIS, M ;

MASSARA, F ;

LANCRANJAN, I ;

CAMANNI, F .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (02) :179-182

[3] EFFECT OF THE NEW ERGOT DERIVATIVE TERGURIDE ON PLASMA PRL AND GH LEVELS IN PATIENTS WITH PATHOLOGICAL HYPERPROLACTINEMIA OR ACROMEGALY [J].

DALLABONZANA, D ;

LIUZZI, A ;

OPPIZZI, G ;

VERDE, G ;

CHIODINI, PG ;

DOROW, R ;

HOROWSKI, R .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1985, 8 (02) :147-151

[4]

Di Salle E, 1982, J ENDOCRINOL INVE S1, V6, P6

[5]

DISALLE E, 1984, J ENDOCRINOL INVE S1, V7, P32

[6] MEDICAL-TREATMENT OF HYPERPROLACTINEMIC DISORDERS [J].

FERRARI, C ;

CROSIGNANI, PG .

HUMAN REPRODUCTION, 1986, 1 (08) :507-514

[7] LONG-LASTING PROLACTIN-LOWERING EFFECT OF CABERGOLINE, A NEW DOPAMINE AGONIST, IN HYPERPROLACTINEMIC PATIENTS [J].

FERRARI, C ;

BARBIERI, C ;

CALDARA, R ;

MUCCI, M ;

CODECASA, F ;

PARACCHI, A ;

ROMANO, C ;

BOGHEN, M ;

DUBINI, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :941-945

[8]

GROSSMAN A, 1986, CLIN ENDOCRINOL OXF, V22, P611

[9]

GROSSMAN A, 1986, CLIN ENDOCRINOL OXF, V24, P31

[10] PROLACTIN-LOWERING EFFECT OF ACUTE AND ONCE WEEKLY REPETITIVE ORAL-ADMINISTRATION OF CABERGOLINE AT 2 DOSE LEVELS IN HYPERPROLACTINEMIC PATIENTS [J].

MATTEI, AM ;

FERRARI, C ;

BAROLDI, P ;

CAVIONI, V ;

PARACCHI, A ;

GALPAROLI, C ;

ROMANO, C ;

SPELLECCHIA, D ;

GEREVINI, G ;

CROSIGNANI, PG .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (01) :193-198

← 1 2 →